Clinical trials: Pathological Gambler
Pathological Gambling
Dopamine Responsivity in Gamblers
This study deals with how people decide between rewards of different value. The investigators want to understand how the brain's dopamine system impacts this kind of decision making.
- Trial name
- NCT02772978
- Testing
- Tolcapone
- Volunteers
- 19 people
- Sponsor
- University of California, San Francisco
Pathological Gambling
Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided Treatment
Research specific to women's gambling treatment needs is limited but suggests a critical need for women sensitive options and reduced barriers to access.
- Trial name
- NCT01743092
- Testing
- Webinar, Tutuorial workbook
- Where
- Canada
- Volunteers
- 59 people
- Sponsor
- Centre for Addiction and Mental Health
Pathological Gambling
D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement
To determine if: 1. pathological gambling is similar to psychostimulant addiction as reflected by parallel roles for D1 and D2 receptors in gambling and stimulant reinforcement. 2.
- Trial name
- HFDEX (NCT02203786)
- Testing
- Haloperidol, Fluphenazine, Dexedrine
- Where
- Canada
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Centre for Addiction and Mental Health
Gambling, Tobacco Use Disorder
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
The objective of this application is to examine whether, given its mechanism of action, the dietary supplement, N-acetyl cysteine (NAC) will reduce both tobacco use and pathological gamblers (PG) symptoms in nicotine dependent…
- Trial name
- NCT00967005
- Testing
- N Acetyl Cysteine, Sugar Pill
- Where
- 2 sites in United States
- Volunteers
- 28 people
- Sponsor
- University of Chicago